TELA Bio
TELA
47 hedge funds and large institutions have $147M invested in TELA Bio in 2021 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 14 increasing their positions, 15 reducing their positions, and 5 closing their positions.
1.34% more ownership
Funds ownership: 67.16% → 68.5% (+1.3%)
1% more capital invested
Capital invested by funds: $146M → $147M (+$1.62M)
0% more funds holding
Funds holding: 47 → 47 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
7% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 15
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PVI
Pura Vida Investments
New York
|
+$1.68M |
| 2 |
EWM
Essex Woodlands Management
The Woodlands,
Texas
|
+$1.58M |
| 3 |
JAMONY
Jacob Asset Management of New York
Hermosa Beach,
California
|
+$1.55M |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$688K |
| 5 |
Renaissance Technologies
New York
|
+$437K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.69M |
| 2 |
RPC
Rossmore Private Capital
Glastonbury,
Connecticut
|
-$519K |
| 3 |
SAM
Silvercrest Asset Management
New York
|
-$450K |
| 4 |
Squarepoint
New York
|
-$408K |
| 5 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$165K |
TELA Hedge Fund Activity: Q1 2021 in Review
47 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in TELA Bio (TELA) for Q1 2021, worth a combined $147M — up 1.1% from $146M a quarter earlier.
Fund positioning in TELA was balanced in Q1 2021: 5 funds opened new positions, 5 closed out, 14 added to existing stakes and 15 trimmed.
The largest buyer was Pura Vida Investments, adding an estimated $1.68M. The largest seller was Alyeska Investment Group, cutting an estimated $1.69M.
- 47 institutional investors held TELA Bio (TELA) as of Q1 2021, unchanged from Q4 2020.
- Funds reported $147M of TELA Bio stock for Q1 2021, up 1.1% quarter-over-quarter.
- 5 funds opened new TELA Bio positions in Q1 2021 and 5 closed out, a net change of 0 holders.
- The largest TELA Bio buyer in Q1 2021 was Pura Vida Investments, an estimated $1.68M added.
- The largest TELA Bio seller in Q1 2021 was Alyeska Investment Group, an estimated $1.69M sold.
Based on aggregated 13F filings for Q1 2021.